Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which our caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; unskilled nursing services; and employer of record support services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers a line of durable medical equipment and enteral nutrition supplies to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
IPO Year: 2021
Exchange: NASDAQ
Website: aveanna.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/13/2023 | Neutral → Underweight | JP Morgan | |
| 11/30/2023 | $1.50 | Sell | UBS |
| 5/12/2023 | Strong Buy → Mkt Perform | Raymond James | |
| 1/27/2023 | $2.00 → $1.00 | Neutral → Underperform | Credit Suisse |
| 11/21/2022 | $7.00 → $3.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 11/17/2022 | $5.50 → $2.00 | Outperform → Neutral | Credit Suisse |
| 7/22/2022 | $2.50 | Buy → Hold | Jefferies |
| 7/5/2022 | Buy → Hold | Truist | |
| 6/21/2022 | $3.00 → $2.00 | Neutral → Underperform | BofA Securities |
| 6/21/2022 | $5.50 → $3.50 | Overweight → Equal-Weight | Stephens |
ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder
ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and
ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t
ATLANTA, June 15, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that David Afshar has resigned from his position as Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer effective July 7, 2023, to pursue other opportunities, and not due to any disagreement with Aveanna's management, operations, policies or practices, including financial matters. "On behalf of the entire Aveanna team, I'd like to thank Dave for his contributions over the last five years. Since joining the Company in February 2018, Dave has been instrumental in building and strengthening our finance team and successfully leading our transi
ATLANTA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that its Chief Executive Officer and Director, Tony Strange, is retiring and will depart the company effective December 31, 2022. Jeff S. Shaner, Aveanna's long serving Chief Operations Officer, will serve as CEO and Director, effective December 31, 2022. "Tony's leadership was a significant part of Aveanna's formation and growth since its inception five years ago. He leaves an enduring legacy of building one of the nation's largest home care companies in America,
Dr. Erica Schwartz joins Butterfly's Board of Directors Troy Quander joins Butterfly as Senior Vice President, Regulatory and Quality Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and contribute to the aspiration of global health equity, today announced the expansion of its Board of Directors to nine directors through the appointment of Dr. Erica Schwartz and the addition of Troy Quander to the leadership team as Senior Vice President, Regulatory and Quality. These appointments continue to strengthen the technical foundation of the company to ensure that it can effectively execute its mission of dem
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20
ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. Management will host 1x1 investor meetings as well as a fireside chat at 11:30 a.m. Eastern Time on the same day, May 20, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is headquart
ATLANTA, April 22, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. Management will host 1x1 investor meetings as well as a presentation at 3:15 p.m. Pacific Time on the same day, May 14, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthc
ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13752435. The replay will be available until May 15, 2025. Int
ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Thrive Skilled Pediatric Care ("Thrive SPC"). The transaction is expected to close in the second fiscal quarter of 2025, subject to customary regulatory approvals. Thrive SPC is one of the largest independent providers of pediatric home care with 23 locations in seven states including Arizona, Georgia, Kansas, New Mexico, North Carolina, Virginia, and Texas. Thrive SPC primarily provides skilled Private Duty Nursing
Fourth Quarter Revenue was $519.9 million, an 8.6% increase over the prior year period Gross margin increased 15.7% to $171.7 million compared to Q4 2023 Fourth Quarter Net income was $29.2 million compared to net loss of $25.7 million for the comparable prior year period Adjusted Net income was $11.1 million, an increase of $14.3 million compared to Q4 2023 Adjusted EBITDA for Q4 2024 was $55.2 million, a 42.8% increase as compared to Q4 2023Full Year 2025 Revenue guidance between $2.10 - $2.12 billion Full Year 2025 Adjusted EBITDA guidance between $190 - $194 million ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:A
ATLANTA, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 13, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13750192. The replay will be available until March
ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2025. Management will present at 10:30 a.m. PST followed by 1x1 investor meetings on the same day, January 15, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is headquarte
Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period Gross margin increased 8.4% to $159.7 million, compared to Q3 2023 Third Quarter Net loss was $42.8 million, compared to net loss of $102.4 million in the comparable prior year period Adjusted Net income was $4.6 million, an increase of $9.3 million over the comparable prior year period Adjusted EBITDA was $47.8 million, a 32.2% increase as compared to the prior year periodFull Year 2024 Revenue guidance raised to approximately $2.0 billion Full Year 2024 Adjusted EBITDA guidance raised to greater than $168 million ATLANTA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)
ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder
JP Morgan downgraded Aveanna from Neutral to Underweight
UBS initiated coverage of Aveanna with a rating of Sell and set a new price target of $1.50
Raymond James downgraded Aveanna from Strong Buy to Mkt Perform
Credit Suisse downgraded Aveanna from Neutral to Underperform and set a new price target of $1.00 from $2.00 previously
RBC Capital Mkts downgraded Aveanna from Outperform to Sector Perform and set a new price target of $3.00 from $7.00 previously
Credit Suisse downgraded Aveanna from Outperform to Neutral and set a new price target of $2.00 from $5.50 previously
Jefferies downgraded Aveanna from Buy to Hold and set a new price target of $2.50
Truist downgraded Aveanna from Buy to Hold
BofA Securities downgraded Aveanna from Neutral to Underperform and set a new price target of $2.00 from $3.00 previously
Stephens downgraded Aveanna from Overweight to Equal-Weight and set a new price target of $3.50 from $5.50 previously
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
10-Q - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
SCHEDULE 13G/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
DEFA14A - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
DEF 14A - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
144 - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)
144 - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)
SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)
SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)
First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20
ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13752435. The replay will be available until May 15, 2025. Int
Fourth Quarter Revenue was $519.9 million, an 8.6% increase over the prior year period Gross margin increased 15.7% to $171.7 million compared to Q4 2023 Fourth Quarter Net income was $29.2 million compared to net loss of $25.7 million for the comparable prior year period Adjusted Net income was $11.1 million, an increase of $14.3 million compared to Q4 2023 Adjusted EBITDA for Q4 2024 was $55.2 million, a 42.8% increase as compared to Q4 2023Full Year 2025 Revenue guidance between $2.10 - $2.12 billion Full Year 2025 Adjusted EBITDA guidance between $190 - $194 million ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:A
ATLANTA, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 13, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13750192. The replay will be available until March
Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period Gross margin increased 8.4% to $159.7 million, compared to Q3 2023 Third Quarter Net loss was $42.8 million, compared to net loss of $102.4 million in the comparable prior year period Adjusted Net income was $4.6 million, an increase of $9.3 million over the comparable prior year period Adjusted EBITDA was $47.8 million, a 32.2% increase as compared to the prior year periodFull Year 2024 Revenue guidance raised to approximately $2.0 billion Full Year 2024 Adjusted EBITDA guidance raised to greater than $168 million ATLANTA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)
ATLANTA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 7, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13748484. The replay will be available until November 14, 2024.
Second Quarter Revenue was $505.0 million, a 7.0% increase over the prior year Gross margin increased 1.9% to $158.3 million, compared to Q2 2023 Second Quarter Net income was $13.9 million, compared to net income of $25.6 million in the comparable prior year period Adjusted Net income was $2.5 million, an increase of $6.6 million over the comparable prior year period Adjusted EBITDA was $45.6 million, a 27.3% increase as compared to the prior year periodFull Year 2024 Revenue guidance raised to greater than $1,985 million Full Year 2024 Adjusted EBITDA guidance raised to greater than $158 million ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDA
ATLANTA, July 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 8, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13746737. The replay will be available until August 15, 2024. Int
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period Adjusted EBITDA was $34.9 million, a 22.5% increase as compared to the prior year quarter Full Year 2024 Revenue guidance raised to greater than $1,970 million Full Year 2024 Adjusted EBITDA guidance raised to greater than $150 million ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13745298. The replay will be available until May 16, 2024. Interest